二级预防

MRI作为一项动脉粥样硬化斑块的定性检查证明了它在缺血性脑卒中二级预防中的潜在价值，为将来使用MRI前瞻性评价卒中二级预防的效果提供了重要的依据。

MRI demonstrated its potential value in secondary prevention of cerebral infarction .

一项比较大剂量阿托伐他汀与常规剂量辛伐他汀用于心肌梗死二级预防的随机对照试验：IDEAL研究

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction : The IDEAL study : A randomized controlled trial

调脂治疗在CHD的一级和二级预防中已得到充分肯定。

The effect of lipid-regulating treatment has been confirmed on one degree and two degree prevention of CHD .

无论选择何种治疗策略，合理使用抗栓药物治疗以及冠心病的二级预防都应该是非ST段抬高急性冠脉综合征患者治疗策略的重要组成部分。

Antithrombotic therapy and the secondary prevention for coronary artery disease should be important elements of any treatment for acute coronary syndrome .

通过监测CRP指导抗炎治疗，可能会在心脑血管病的一、二级预防中发挥重要作用。

CRP-guided anti-inflammation therapeutic strategy may play an important part in the primary and secondary prevention of the cardio-cerebrovascular diseases .

ACEI在卒中二级预防中的作用

Application of ACEI for Secondary Prevention of Stroke

结论重视CHD，特别是中青年组病人的调脂治疗，调脂治疗为CHD二级预防的重要措施。

Conclusion It is a very important measure to modify lipid for coronary secondary prevention , especially in young and middle aged patients .

加强PCI时动脉粥样硬化斑块的危险分层和术后二级预防，有望进一步提高糖尿病合并冠心病患者的总体PCI疗效。

Enhancement of plaque risk stratification during the procedure and secondary prevention during follow-up may further improve the overall outcomes of PCI for patients with diabetes .

目的通过经济发达地区社区人群冠状动脉心脏病（CHD）风险评估，筛选CHD一、二级预防的对象。

Objective To screen the subjects for primary and secondary prevention of coronary heart disease ( CHD ) in the population in the economy developed region .

PROactive研究中2型糖尿病患者大血管事件的二级预防：一项随机对照研究

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study ( PROspective pioglitAzone Clinical Trial in macroVascular Events ): A randomised controlled trial

目的：研究本地区不同年龄急性心肌梗死（AMI）患者血脂水平状况及冠心病（CHD）二级预防中的调脂治疗。

Objective : To study the serum lipid levels among different age groups patients with acute myocardial infarction ( AMI ) and the use of lipid lowering pharmacotherapy in coronary secondary prevention .

结论HDL-C在稳定动脉粥样硬化（AS）斑块，预防AMI的发生方面起着重要作用。重视CHD，特别是中青年组病人的调脂治疗，调脂治疗为CHD二级预防的重要措施。

Conclusion It is very important that role to Keep atherosclerosis plaque and preventive occurrence in AMI by HDL-C and measure to modify lipid for coronary secondary prevention , especially in young-middle-aged patients .

临床工作中许多住院冠心病患者为再次住院的患者，加强对CHD危险因素的控制和干预，重视CHD的干预治疗即二级预防以降低心血管临床事件，显得尤为重要。

Many patients are readmission , to strengthen the control of risk factors for CHD and intervention , emphasis on secondary prevention of CHD , to reduce cardiovascular clinical events , it is particularly important .

对需加强抗聚的患者，在监测下小剂量的ASA和TIC合用有较好的价/效比，可做为高危ICVD二级预防的一种选择。

For patients who need stronger anti-platelet therapy , the combined therapy has rather better cost / efficacy ratio under monitoring , and it might be a choice of secondary prevention of ICVD .

目的了解广州市番禺地区人群鼻咽癌（NPC）检出率和血清EB病毒衣壳抗原抗体（EBVCA-IgA）反应现状和流行趋势，为该地区NPC二级预防提供临床依据。

OBJECTIVE : To describe nasopharyngeal carcinoma ( NPC ) detection Rate and the epidemic trends of serum EB virus capsular antigen ( EBVCA ) IgA antibody in Guangzhou Panyu district and provide evidence for secondary prevention of NPC .

引言：个体化抗凝策略是静脉血栓栓塞VTE二级预防的关键，并取决于对患者复发风险的正确评估。

Introduction : Individualized anticoagulant strategy is crucial in secondary prophylaxis of venous thromboembolism ( VTE ) and depends on accurate assessment of recurrent risk in the individual patient .

结论：复方丹参滴丸在TIA的二级预防中，有肯定的疗效，且无明显副作用，可作为预防和治疗脑血管疾病的药物之一。

Conclusion : In the secondary prevention TIA , Compound Danshen Dropping Pills had certain effect and side-effect was not evident , so it could be used in the prevention and treatment in myocardial and cerebral vascular disease .

大量研究表明他汀类药物在心血管疾病一级预防和二级预防中具有显著疗效，并且与低密度脂蛋白胆固醇（LDL-C）降低的幅度密切相关，强化调脂的概念已经受到广泛重视。

Accumulated clinical trials have demonstrated the clinical efficacy of statins , which is closely associated with the magnitude of LDL-C reduction , in primary and secondary prevention of cardiovascular diseases . The concept of intensive LDL-C lowing has been widely accepted .

他汀类药物在缺血性卒中二级预防中的作用有待于强化降低胆固醇水平卒中预防研究（SPARCL）的证实。

The effect of statins in the secondary prevention of ischemic stroke remains to be confirmed by the Stroke Prevention by Aggressive Reduction in Cholesterol Levels ( SPARCL ) Study .

循证医学二级预防指南与实践的距离

Difference of Guideline and Practice for Secondary Prevention in Evidence-based Medicine

钙拮抗剂对高血压病二级预防的探讨

Effect of Calcium Antagonists on the Secondary Prevention of Essential Hypertension

脑卒中后患者二级预防护理干预的效果观察

Observation of effect of behavioral intervention of secondary prevention on stroke

血栓前状态指标在缺血性脑血管病二级预防中的作用

Prethrombotic state index in the secondary prevention of ischemic cerebrovascular diseases

对冠心病循证二级预防治疗的长期坚持

Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease

原发性肝癌二级预防的随机分组前瞻性研究

Randomized controlled prospective study of secondary prevention for primary liver cancer

急性心肌梗死并脑卒中二级预防的循证医学证据

Evidence-based medicine for secondary prevention of acute myocardial infarction-stroke combination

1200例女性乳腺癌的年龄特点及二级预防

Age analysis of female breast cancer and secondary prevention & 120o cases

中国人群2002年慢性非传染性疾病二级预防措施的执行情况

Implementation of second prevention measures on Chronic Diseases in Chinese , 2002

联合应用双嘧达莫和阿司匹林在卒中二级预防中的疗效评价

Evaluation of Dipyridamole and Acetylsalicylic Acid in the Secondary Prevention of Stroke

女性乳腺癌二级预防策略简介

Brief Introduction of Secondary Prevention Strategy for Female Breast Cancer